SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-048790
Filing Date
2021-09-20
Accepted
2021-09-20 13:09:23
Documents
17
Period of Report
2021-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147663-8k_inmed.htm   iXBRL 8-K 40741
2 NEWS RELEASE, DATED SEPTEMBER 17, 2021 ea147663ex99-1_inmed.htm EX-99.1 14093
3 NEWS RELEASE, DATED SEPTEMBER 17, 2021 ea147663ex99-2_inmed.htm EX-99.2 9284
8 GRAPHIC ex99-1_001.jpg GRAPHIC 16784
9 GRAPHIC ex99-2_001.jpg GRAPHIC 16795
  Complete submission text file 0001213900-21-048790.txt   332593

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20210917.xsd EX-101.SCH 3267
5 XBRL DEFINITION FILE inm-20210917_def.xml EX-101.DEF 26194
6 XBRL LABEL FILE inm-20210917_lab.xml EX-101.LAB 35951
7 XBRL PRESENTATION FILE inm-20210917_pre.xml EX-101.PRE 24852
10 EXTRACTED XBRL INSTANCE DOCUMENT ea147663-8k_inmed_htm.xml XML 4323
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211262623
SIC: 2834 Pharmaceutical Preparations